Bahareh Eftekharzadeh, Pharm.D., Ph.D. Boston, MA | [email protected] | LinkedIn Professional Summary Scientific and strategic biotechnology leader with 12+ years of experience building drug discovery platforms and advancing first-in-class small-molecule therapeutics from discovery through IND. Deep expertise in neuroscience, oncology, high-throughput screening, translational biomarkers, and automation-enabled assay development. Core Expertise Neuroscience & Oncology Drug Discovery | High-Throughput Screening | Translational Biomarkers | Assay Development | Automation Platforms | IND Strategy | Program Leadership | Venture Formation Professional Experience Astronautx - Senior Director of Discovery Biology Nereid Therapeutics – Senior Director, Drug Discovery & Development (2025–Present) • Product lead for oncology and neuroscience programs • Led biomarker strategies and translational planning • Built cross-functional teams and CRO partnerships Nereid Therapeutics – Head of Neuroscience & HTS (2020–2025) • Built HTS and automation platform • Discovered TDP-43 direct binder program Flagship Pioneering / ProFound – Principal Scientist (2020) • Built target discovery platform Neuron23 – Senior Scientist (2018–2020) • Advanced LRRK2 and TYK2 programs Biogen – Scientist (2018) • ALS and Movement Disorders Research Education Ph.D., Structural Biology & Biophysics – Universitat de Barcelona Pharm.D. – Tehran University of Medical Sciences Postdoctoral Fellowship – Massachusetts General Hospital / Harvard Medical School Honors & Awards SLAS Innovation Award Nominee (2024) IndieBio Venture Ideation Award ($250K) Charles & Helen Schwab Foundation Research Grant Outstanding Presentation Award, NYAS Elite PhD Fellowship, La Caixa Foundation